Effect of arsenic trioxide on human hepatocellular carcinoma HepG2 cells: Inhibition of proliferation and induction of apoptosis
- 1 June 2002
- journal article
- Published by Elsevier in Life Sciences
- Vol. 71 (3) , 275-285
- https://doi.org/10.1016/s0024-3205(02)01622-3
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Pathologic, Cytogenetic and Molecular Assessment of Acute Promyelocytic Leukemia Patients Treated with Arsenic Trioxide (As2O3)Laboratory Investigation, 2000
- Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemiaLeukemia, 2000
- Effect of Arsenic Trioxide on Cell Cycle Arrest in Head and Neck Cancer Cell Line PCI-1Biochemical and Biophysical Research Communications, 1999
- Induction of apoptosis and inhibition of human gastric cancer MGC-803 cell growth by arsenic trioxideEuropean Journal Of Cancer, 1999
- Arsenic trioxide induces apoptosis in neuroblastoma cell lines through the activation of caspase 3 in vitroFEBS Letters, 1999
- Apoptosis and Growth Inhibition in Malignant Lymphocytes After Treatment With Arsenic Trioxide at Clinically Achievable ConcentrationsJNCI Journal of the National Cancer Institute, 1999
- Arsenic Trioxide, a Novel Mitochondriotoxic Anticancer Agent?JNCI Journal of the National Cancer Institute, 1999
- Arsenic Trioxide and Melarsoprol Induce Programmed Cell Death in Myeloid Leukemia Cell Lines and Function in a PML and PML-RAR Independent MannerBlood, 1998
- Arsenic-induced PML targeting onto nuclear bodies: Implications for the treatment of acute promyelocytic leukemiaProceedings of the National Academy of Sciences, 1997
- Ancient Remedy Performs New TricksScience, 1996